GDF-15 is a new biomarker in STEMI that provides prognostic information beyond established clinical and biochemical markers.
No takes yet. Share an insight, caveat, or question.
Kempf et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: